Pharmica.co.uk: Medication and Disease Information Portal - Page 2

Clinical Trial Data vs Real-World Side Effects: What You Need to Know

Clinical Trial Data vs Real-World Side Effects: What You Need to Know

Clinical trials reveal basic side effects, but real-world data uncovers hidden risks. Learn how FDA-approved drug safety profiles differ from what patients actually experience-and what you need to know.

Read More
Why Generic Drugs Cost 80-85% Less Than Brand-Name Drugs

Why Generic Drugs Cost 80-85% Less Than Brand-Name Drugs

Generic drugs cost 80-85% less than brand-name drugs because they don't require expensive clinical trials or marketing. They contain the same active ingredients and meet the same safety standards, but compete in a free market that drives prices down.

Read More
Pharmacokinetic Studies: The Real Standard for Proving Generic Drug Equivalence

Pharmacokinetic Studies: The Real Standard for Proving Generic Drug Equivalence

Pharmacokinetic studies are the main method used to prove generic drugs work like brand-name versions, but they’re not perfect. Learn how they work, where they fall short, and what’s changing in drug approval.

Read More
Opioid Monitoring During Treatment: How Urine Drug Screens and Risk Stratification Improve Safety

Opioid Monitoring During Treatment: How Urine Drug Screens and Risk Stratification Improve Safety

Urine drug screens and risk stratification are essential for safe opioid treatment. Learn how testing works, why false negatives happen, and how clinicians use risk scores to prevent overdose.

Read More
Frequent Urination and Urgency from Medications: Common Bladder Side Effects

Frequent Urination and Urgency from Medications: Common Bladder Side Effects

Frequent urination and urinary urgency are common but often overlooked side effects of medications like diuretics, antidepressants, and blood pressure drugs. Learn which drugs cause bladder problems and how to manage them without stopping essential treatments.

Read More
Cost-Effectiveness Analysis: Measuring the Value of Generic Drugs

Cost-Effectiveness Analysis: Measuring the Value of Generic Drugs

Cost-effectiveness analysis reveals how generic drugs save billions - but not all generics are cheap. Learn why some cost 20x more than alternatives and how to spot real savings.

Read More
Anticholinergic Burden in Older Adults: How Common Medications Affect Memory and Thinking

Anticholinergic Burden in Older Adults: How Common Medications Affect Memory and Thinking

Many common medications for allergies, bladder issues, and depression in older adults carry hidden risks to memory and thinking. Learn how anticholinergic burden increases dementia risk and what safer alternatives exist.

Read More
Fertility and Immunosuppressants: What You Need to Know About Medication Risks and Planning

Fertility and Immunosuppressants: What You Need to Know About Medication Risks and Planning

Immunosuppressants can affect fertility and pregnancy outcomes. Learn which drugs are safe, which to avoid, and how to plan ahead for a healthy pregnancy while managing autoimmune disease or transplant recovery.

Read More
Chronic Conditions: How to Adjust to Generic Maintenance Medications Without Compromising Your Health

Chronic Conditions: How to Adjust to Generic Maintenance Medications Without Compromising Your Health

Switching to generic maintenance medications can save hundreds per month-but not everyone adjusts easily. Learn when generics work, when to be cautious, and how to manage the transition safely for chronic conditions like diabetes, thyroid disease, and high blood pressure.

Read More
Generic Prescribing Incentives: How States Push Doctors and Pharmacies to Choose Cheaper Drugs

Generic Prescribing Incentives: How States Push Doctors and Pharmacies to Choose Cheaper Drugs

States use copay differentials, pharmacist substitution rules, and preferred drug lists to push doctors and patients toward cheaper generic medications. These policies save billions but face challenges from rebate systems and supply shortages.

Read More